查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
重组蛋白市场规模、份额、趋势分析报告，按宿主细胞（昆虫细胞、哺乳动物）、应用（研究、治疗）、产品/服务、最终用户、地区、细分市场、2022~2030 年预测
市场调查报告书
商品编码
1122234

重组蛋白市场规模、份额、趋势分析报告，按宿主细胞（昆虫细胞、哺乳动物）、应用（研究、治疗）、产品/服务、最终用户、地区、细分市场、2022~2030 年预测

Recombinant Proteins Market Size, Share & Trends Analysis Report By Host Cell (Insect Cells, Mammalian), By Application (Research, Therapeutics), By Product & Services, By End-user, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

重组蛋白市场增长和趋势

根据 Grand View Research, Inc. 的一份新报告，预计到 2030 年，重组蛋白的全球市场规模将达到 50.9 亿美元，在预测期内的复合年增长率为 12.0%。多发性硬化症、中性粒细胞减少症、中风、贫血和侏儒症等疾病正变得司空见惯，推动了对重组蛋白药物的需求。此外，由于癌症发病率和患病率的上升以及研发活动的扩大，对生物仿製药、生物製剂和重组蛋白开发的关注正在增加。

根据美国癌症协会的数据，到 2022 年，将有 190 万例新癌症病例和 609,360 例癌症相关死亡。此外，重组蛋白在 ELISA、蛋白质印迹和免疫组织化学 (IHC) 等临床诊断中的应用不断扩大，预计将推动市场扩张。由于研发成本上升、癌症患者数量增加以及对新颖和个性化治疗的需求等因素，预计全球行业将在预测期内显着扩张。由于努力了解病毒动力学，重组蛋白领域的研究活动随着 COVID-19 大流行而增加。通过量身定制的治疗方法，重组蛋白的产量显着增加。

此外，随着研究资金变得更加容易获得，预计重组蛋白的需求和生产，尤其是与 COVID-19 相关的免疫反应蛋白，将会增加。重组蛋白质被认为是天然蛋白质的改进版本，可以通过多种方式生产以提高蛋白质产量、创造有用的商业产品或改变基因序列。製药公司不断增加的研发支出、慢性病的高发病率、不断增加的监管要求以及减少病毒感染的持续需求是全球行业的主要驱动力。

在预测期内，预计全球行业将受到重组蛋白合成技术进步的推动。例如，2022年6月，根据美国生物技术信息中心提供的数据，CRISPR/Cas9、TALENs、锌指介导、转基因或顺基因技术等新育种技术无法进行离体基因编辑或基因操作。 . 较新的技术，更容易获批，有这样的技术。由于人口老龄化、收入水平上升、医疗保健基础设施改善、医疗保健成本上升以及新兴经济体低成本製造业的好处，行业参与者也有望在该地区投资，从而推动市场增长。

重组蛋白市场报告亮点

按产品和服务来看，产品类别将在 2021 年占销售额的最大份额。生物医学研究对重组蛋白产品的需求以及抗癌研究和开发的资金不断增加，在全球范围内增加了对重组蛋白产品的需求

由于代谢紊乱、癌症、遗传疾病和免疫紊乱等多种疾病的流行，治疗药物应用板块在 2021 年的收入份额占比最大。

製药和生物技术公司的最终用户部门看到主要市场参与者增加了对研发的投资，以提高研究生产力并扩大产品供应以创收，从而在 2021 年引领全球行业。

由于哺乳动物系统广泛用于重组蛋白生产，该部分在 2021 年的收入份额占最大份额

由于慢性病发病率上升、尖端疗法的使用、主要参与者的存在以及医疗保健成本上升，北美将在 2021 年成为主要地区。

由于研发活动增加、可支配收入增加以及患者对蛋白质疗法的了解提高，预计亚太地区将在预测期内以最快的速度增长。

此外，印度和中国预计将在亚太地区快速增长

内容

第一章研究方法

  • 市场细分和范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • Gvr 内部数据库
    • 辅助信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法估算国别市场
  • 全球市场：CAGR 计算
  • 调查假设
  • 二级信息列表
  • 主要信息列表
  • 目的

第 2 章执行摘要

  • 市场展望
  • 市场概览

第 3 章市场变量、趋势和范围

  • 市场趋势和前景
  • 市场细分和范围
  • 市场动态
    • 市场驱动因素分析
      • 增加药物开发和精准医学的研究活动
      • 生物製剂和生物仿製药的采用率增加
      • 增加对研发活动的投资
    • 市场约束分析
      • 蛋白质生产的监管和安全问题
      • 缺乏熟练的人员和专业知识
    • 市场机会分析
      • 治疗性重组蛋白的成本降低和生物仿製药的出现
      • 创新技术可降低重组蛋白生产成本
  • 商业环境分析工具
    • 害虫的 SWOT 分析
    • 波特五力分析
  • 2021 年产品渗透率和增长前景图
  • 重组蛋白市场：COVID-19 的影响分析

第四章产品细分分析

  • 重组蛋白市场：产品差异分析
  • 产品
    • 细胞因子和生长因子
      • 干扰素
      • 白细胞介素
      • 其他
    • 抗体
    • 免疫检查点蛋白
    • 病毒抗原
    • □
      • 激□
      • 代谢□
      • 其他
    • 重组调节蛋白
    • 激素
    • 其他
  • 製作服务

第五章应用细分分析

  • 重组蛋白市场：应用变化分析
  • 药物发现和开发
  • 治疗学
    • 生物製品
    • 疫苗
    • 细胞和基因治疗
    • 其他
  • 调查
  • 其他

第 6 章最终用户细分分析

  • 重组蛋白市场：最终用户差异分析
  • 製药和生物技术公司
  • 学术和研究机构
  • 诊断实验室
  • 其他

第 7 章宿主细胞片段分析

  • 重组蛋白市场：宿主细胞的变异分析
  • 哺乳动物系统
  • 昆虫细胞
  • 酵母和真菌
  • 细菌细胞
  • 其他

第八章区域展望

  • 重组蛋白市场：区域差异分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲 (Mea)
    • 南非
    • Ue
    • 沙特阿拉伯

第 9 章竞争格局

  • 战略框架
  • 市场参与的分类
  • 公司简介
    • Thermo Fisher Scientific, Inc.
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • Abcam plc
      • 公司概况
      • 财务表现
      • 产品/服务基准
      • 战略举措
    • Bio-Rad Laboratories, Inc.
      • 公司概况
      • 财务表现
      • 产品/服务基准
      • 战略举措
    • Bio-Techne Corporation
      • 公司概况
      • 研发体系
      • 财务表现
      • 产品基准
      • 战略举措
    • Merck KGaA
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • GenScript Biotech Corporation
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • RayBiotech Life, Inc.
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • Proteintech Group, Inc.
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • Enzo Life Sciences, Inc.
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • STEMCELL Technologies Inc
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • Sino Biological, Inc.
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • Abnova Corporation
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
Product Code: GVR-4-68039-974-2

Recombinant Proteins Market Growth & Trends:

The global recombinant proteins market size is expected to reach USD 5.09 billion by 2030, registering a CAGR of 12.0% over the forecast period, according to a new report by Grand View Research, Inc. Diseases like multiple sclerosis, neutropenia, cerebral apoplexy, anemia, and others, as well as dwarfism, are becoming more common, which is driving up the demand for recombinant protein drugs. Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth.The focus on the development of biosimilars, biologics, and recombinant proteins has increased owing to a rise in the incidence and prevalence of cancer and the expansion of research & development activity.

According to the American Cancer Society, in 2022, there will be 1.9 million new cases of cancer and 609,360 cancer-related deaths. In addition, the expanding application of recombinant proteins in clinical diagnostic methods including ELISA, Western Blotting, and Immunohistochemistry (IHC) is anticipated to fuel market expansion. Due to factors including rising R&D spending, an increase in the number of cancer patients, and the desire for novel & tailored therapies, the global industry is anticipated to expand significantly during the forecast period.Research activity in recombinant protein space has increased in response to the COVID-19 pandemic as a result of efforts to comprehend the dynamics of the virus. The production of recombinant proteins has increased significantly, along with tailored treatment.

In addition, research funding is predicted to become more readily available along with an increase in demand for and production of recombinant proteins, particularly those immune response proteins associated with COVID-19. Therefore, positive effects have been seen for the companies offering products specifically made for COVID-19.Recombinant protein is viewed as a modified version of natural protein that can be produced in a number of ways to improve protein output, create useful commercial goods, and alter gene sequences. The rise in pharmaceutical firms' R&D expenditures, high incidence of chronic illnesses, an increase in the number of regulatory requirements, and the ongoing need to reduce viral infections are the main drivers of the global industry.

Over the projected period, the global industry is anticipated to be driven by technological advancements in the synthesis of recombinant proteins. For instance, in June 2022, according to the data produced by the National Center for Biotechnology Information, new breeding techniques, such as CRISPR/Cas9, TALEN, and Zinc Finger mediated, as well as transgenic or cis-genic techniques, are emerging technologies that may make it easier for in vitro genetic editing or manipulation of the genes to be approved. In addition, industry participants are anticipated to invest in the region due to the aging population, rising income levels, better healthcare infrastructure, rising healthcare spending, and the advantages of low-cost manufacturing in developing nations, thereby propelling market growth.

Recombinant Proteins Market Report Highlights:

  • By product & services, the product segment accounted for the largest revenue share in 2021. The demand is increasing globally due to the need for recombinant protein products in biomedical research and increased funding for R&D in the fight against cancer
  • The therapeutics application segment held themaximum revenue share in 2021 due to the prevalence of various diseases, such as metabolic disorders, cancer, genetic disorders, and immune diseases
  • The pharma & biotech companies end-user segment led the global industry in 2021 due to the increasing investments by key market players in their R&D segment to increase research productivity and grow their offerings for revenue generation
  • Mammalian systems are widely used in the production of recombinant proteins, thus, this segment accounted for the largest revenue share in 2021
  • North America was the dominant region in 2021 dueto an increase in the incidence of chronic diseases, use of cutting-edge treatments, presence of key players, and rise in healthcare spending in the region
  • Asia Pacific is expected to grow at the fastestCAGRover the projected period due to an uptick in R&D activity, an increase in disposable incomes, and a better understanding of protein therapies among patients
  • India and China are additionally anticipated to see rapid growth in the AsiaPacific region

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
  • 1.7 Global Market: Cagr Calculation
  • 1.8 Research Assumptions
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Outllook
  • 2.2 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Trends & Outlook
  • 3.2 Market Segmentation And Scope
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Growing Research Activities For Drug Development And Precision Medicine
      • 3.3.1.2 Rising Adoption Of Biologics And Biosimilars
      • 3.3.1.3 Increasing Investments In Research & Development Activities
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Regulatory And Safety Concerns With Protein Production
      • 3.3.2.2 Dearth Of Skilled Personnel And Expertise
    • 3.3.3 Market Opportunity Analysis
      • 3.3.3.1 Declining Cost Of Therapeutics Recombinant Proteins And Advent Of Biosimilars
      • 3.3.3.2 Innovative Techniques Can Decrease The Recombinant Protein Production Cost
  • 3.4 Business Environment Analysis Tools
    • 3.4.1 Swot Analysis, By Pest
    • 3.4.2 Porter's Five Forces Analysis
  • 3.5 Penetration & Growth Prospect Mapping For Product, 2021
  • 3.6 Recombinant Proteins Market: Covid-19 Impact Analysis

Chapter 4 Product Segment Analysis

  • 4.1 Recombinant Proteins Market: Product Movement Analysis
  • 4.2 Product
    • 4.2.1 Global Recombiant Proteins Product Market, 2018 - 2030 (USD Million)
    • 4.2.2 Cytokines &Growth Factors
      • 4.2.2.1 Global Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
      • 4.2.2.1.1 Interferons
      • 4.2.2.1.1.1 Global Interferons Market, 2018 - 2030 (USD Million)
      • 4.2.2.1.2 Interleukins
      • 4.2.2.1.2.1 Global Interleukins Market, 2018 - 2030 (USD Million)
      • 4.2.2.1.3 Others
      • 4.2.2.1.3.1 Others Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
    • 4.2.3 Antibodies
      • 4.2.3.1 Global Antibodies Market, 2018 - 2030 (USD Million)
    • 4.2.4 Immune Checkpoint Proteins
      • 4.2.4.1 Global Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
    • 4.2.5 Virus Antigens
      • 4.2.5.1 Global Virus Antigens Market, 2018 - 2030 (USD Million)
    • 4.2.6 Enzymes
      • 4.2.6.1 Global Enzymes Market, 2018 - 2030 (USD Million)
      • 4.2.6.1.1 Kinases
      • 4.2.6.1.1.1 Global Kinases Market, 2018 - 2030 (USD Million)
      • 4.2.6.1.2 Metabolic Enzymes
      • 4.2.6.1.2.1 Global Metabolic Enzymes Market, 2018 - 2030 (USD Million)
      • 4.2.6.1.3 Others
      • 4.2.6.1.3.1 Others Enzymes Market, 2018 - 2030 (USD Million)
    • 4.2.7 Recombinant Regulatory Proteins
      • 4.2.7.1 Global Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
    • 4.2.8 Hormones
      • 4.2.8.1 Global Hormones Market, 2018 - 2030 (USD Million)
    • 4.2.9 Others
      • 4.2.9.1 Others Product Market, 2018 - 2030 (USD Million)
  • 4.3 Production Services
    • 4.3.1 Global Recombiant Proteins Production Services Market, 2018 - 2030 (USD Million)

Chapter 5 Application Segment Analysis

  • 5.1 Recombinant Proteins Market: Application Movement Analysis
  • 5.2 Drug Discovery & Development
    • 5.2.1 Global Drug Discovery & Development, 2018 - 2030 (USD Million)
  • 5.3 Therapeutics
    • 5.3.1 Global Therpeutics Market, 2018 - 2030 (USD Million)
    • 5.3.2 Biologics
      • 5.3.2.1 Global Biologics Market, 2018 - 2030 (USD Million)
    • 5.3.3 Vaccines
      • 5.3.3.1 Global Vaccines Market, 2018 - 2030 (USD Million)
    • 5.3.4 Cell & Gene Therapies
      • 5.3.4.1 Global Cell & Gene Therapies Market, 2018 - 2030 (USD Million)
    • 5.3.5 Others
      • 5.3.5.1 Others Therapeutics Market, 2018 - 2030 (USD Million)
  • 5.4 Research
    • 5.4.1 Global Research Market, 2018 - 2030 (USD Million)
  • 5.5 Other
    • 5.5.1 Other Application Market, 2018 - 2030 (USD Million)

Chapter 6 End-User Segment Analysis

  • 6.1 Recombinant Proteins Market: End-User Movement Analysis
  • 6.2 Pharmaceutical & Biotechnology Companies
    • 6.2.1 Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3 Academic & Research Institutes
    • 6.3.1 Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.4 Diagnostic Laboratories
    • 6.4.1 Global Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • 6.5 Others
    • 6.5.1 Other End-Users, 2018 - 2030 (USD Million)

Chapter 7 Host-Cells Segment Analysis

  • 7.1 Recombinant Proteins Market: Host-Cells Movement Analysis
  • 7.2 Mammalian Systems
    • 7.2.1 Global Mammalian Systems Market, 2018 - 2030 (USD Million)
  • 7.3 Insects Cells
    • 7.3.1 Global Insects Cells Market, 2018 - 2030 (USD Million)
  • 7.4 Yeast & Fungi
    • 7.4.1 Global Yeast & Fungi Market, 2018 - 2030 (USD Million)
  • 7.5 Bacterial Cells
    • 7.5.1 Global Bacterial Cells Market, 2018 - 2030 (USD Million)
  • 7.6 Others
    • 7.6.1 Other Host-Cells, 2018 - 2030 (USD Million)

Chapter 8 Regional Outlook

  • 8.1 Recombinant Proteins Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.2 U.K.
      • 8.3.2.1 U.K. Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.3 Germany
      • 8.3.3.1 Germany Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 France Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Italy Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Sain Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.2 China
      • 8.4.2.1 China Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.3 India
      • 8.4.3.1 India Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.4 Japan
      • 8.4.4.1 Japan Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.5 Australia
      • 8.4.5.1 Australia Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.6 Middle East And Africa (Mea)
    • 8.6.1 Mea Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.3 Uae
      • 8.6.3.1 Uae Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.4 Saudi Arabia
      • 8.6.4.1 Saudi Arabia Recombinant Proteins Market, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Strategy Framework
  • 9.2 Market Participation Categorization
  • 9.3 Company Profiles
    • 9.3.1 Thermo Fisher Scientific, Inc.
      • 9.3.1.1 Company Overview
      • 9.3.1.2 Financial Performance
      • 9.3.1.3 Product Benchmarking
      • 9.3.1.4 Strategic Initiatives
    • 9.3.2 Abcam plc
      • 9.3.2.1 Company Overview
      • 9.3.2.2 Financial Performance
      • 9.3.2.3 Product/Service Benchmarking
      • 9.3.2.4 Strategic Initiatives
    • 9.3.3 Bio-Rad Laboratories, Inc.
      • 9.3.3.1 Company Overview
      • 9.3.3.2 Financial Performance
      • 9.3.3.3 Product/Service Benchmarking
      • 9.3.3.4 Strategic Initiatives
    • 9.3.4 Bio-Techne Corporation
      • 9.3.4.1 Company Overview
      • 9.3.4.1.1 R&D Systems
      • 9.3.4.2 Financial Performance
      • 9.3.4.3 Product Benchmarking
      • 9.3.4.4 Strategic Initiatives
    • 9.3.5 Merck KGaA
      • 9.3.5.1 Company Overview
      • 9.3.5.2 Financial Performance
      • 9.3.5.3 Product Benchmarking
      • 9.3.5.4 Strategic Initiatives
    • 9.3.6 GenScript Biotech Corporation
      • 9.3.6.1 Company Overview
      • 9.3.6.2 Financial Performance
      • 9.3.6.3 Product Benchmarking
      • 9.3.6.4 Strategic Initiatives
    • 9.3.7 RayBiotech Life, Inc.
      • 9.3.7.1 Company Overview
      • 9.3.7.2 Financial Performance
      • 9.3.7.3 Product Benchmarking
      • 9.3.7.4 Strategic Initiatives
    • 9.3.8 Proteintech Group, Inc.
      • 9.3.8.1 Company Overview
      • 9.3.8.2 Financial Performance
      • 9.3.8.3 Product Benchmarking
      • 9.3.8.4 Strategic Initiatives
    • 9.3.9 Enzo Life Sciences, Inc.
      • 9.3.9.1 Company Overview
      • 9.3.9.2 Financial Performance
      • 9.3.9.3 Product Benchmarking
      • 9.3.9.4 Strategic Initiatives
    • 9.3.10 STEMCELL Technologies Inc
      • 9.3.10.1 Company Overview
      • 9.3.10.2 Financial Performance
      • 9.3.10.3 Product Benchmarking
      • 9.3.10.4 Strategic Initiatives
    • 9.3.11 Sino Biological, Inc.
      • 9.3.11.1 Company Overview
      • 9.3.11.2 Financial Performance
      • 9.3.11.3 Product Benchmarking
      • 9.3.11.4 Strategic Initiatives
    • 9.3.12 Abnova Corporation
      • 9.3.12.1 Company Overview
      • 9.3.12.2 Financial Performance
      • 9.3.12.3 Product Benchmarking
      • 9.3.12.4 Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 4 Global Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 5 Global Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 6 Global Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 7 Global Recombinant Protein Market, by Region, 2018 - 2030 (USD Million)
  • TABLE 8 North America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 9 North America Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 10 North America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 11 North America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 12 North America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 13 US Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 14 US Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 15 US Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 16 US Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 17 Canada Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 18 Canada Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 19 Canada Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 20 Canada Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 21 Europe Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 22 Europe Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 23 Europe Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 24 Europe Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 25 Europe Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 26 Germany Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 27 Germany Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 28 Germany Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 29 Germany Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 30 UK Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 31 UK Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 32 UK Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 33 UK Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 34 France Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 35 France Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 36 France Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 37 France Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 38 Italy Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 39 Italy Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 40 Italy Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 41 Italy Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 42 Spain Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 43 Spain Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 44 Spain Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 45 Spain Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 48 Asia Pacific Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 49 Asia Pacific Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 50 Asia Pacific Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 51 China Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 52 China Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 53 China Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 54 China Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 55 Japan Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 56 Japan Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 57 Japan Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 58 Japan Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 59 India Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 60 India Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 61 India Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 62 India Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 63 South Korea Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 64 South Korea Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 65 South Korea Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 66 South Korea Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 67 Australia Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 68 Australia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 69 Australia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 70 Australia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 71 Latin America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 72 Latin America Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 73 Latin America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 74 Latin America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 75 Latin America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 76 Brazil Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 77 Brazil Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 78 Brazil Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 79 Brazil Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 80 Mexico Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 81 Mexico Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 82 Mexico Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 83 Mexico Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 84 Argentina Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 85 Argentina Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 86 Argentina Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 87 Argentina Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 88 Middle East & Africa Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 89 Middle East & Africa Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 90 Middle East & Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 91 Middle East & Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 92 Middle East & Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 93 South Africa Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 94 South Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 95 South Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 96 South Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 97 Saudi Arabia Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 98 Saudi Arabia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 99 Saudi Arabia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 100 Saudi Arabia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • TABLE 101 UAE Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 102 UAE Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • TABLE 103 UAE Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • TABLE 104 UAE Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Recombinant Protein, Market Segmentation
  • FIG. 8 Market Snapshot, 2021
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • FIG. 16 Global Recombinant Protein Market: Product & Services Movement Analysis
  • FIG. 17 Global Recombinant Protein Market, for Product, 2018 - 2030 (USD Million)
  • FIG. 18 Global Recombinant Protein Market, for Production Services, 2018 - 2030 (USD Million)
  • FIG. 19 Global Recombinant Protein Market: Application Movement Analysis
  • FIG. 20 Global Recombinant Protein Market, for Drug Discovery & Development, 2018 - 2030 (USD Million)
  • FIG. 21 Global Recombinant Protein Market, for Therapeutics, 2018 - 2030 (USD Million)
  • FIG. 22 Global Recombinant Protein Market, for Research , 2018 - 2030 (USD Million)
  • FIG. 23 Global Recombinant Protein Market, for Others, 2018 - 2030 (USD Million)
  • FIG. 24 Global Recombinant Protein Market: End Use Movement Analysis
  • FIG. 25 Global Recombinant Protein Market, for Pharma & Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 26 Global Recombinant Protein Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • FIG. 27 Global Recombinant Protein Market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • FIG. 28 Global Recombinant Protein Market, for Others , 2018 - 2030 (USD Million)
  • FIG. 29 Global Recombinant Protein Market: Host Cell Movement Analysis
  • FIG. 30 Global Recombinant Protein Market, for Mammalian systems, 2018 - 2030 (USD Million)
  • FIG. 31 Global Recombinant Protein Market, for Insect Cells, 2018 - 2030 (USD Million)
  • FIG. 32 Global Recombinant Protein Market, for Yeast & Fungi, 2018 - 2030 (USD Million)
  • FIG. 33 Global Recombinant Protein Market, for Bacterial Cells, 2018 - 2030 (USD Million)
  • FIG. 34 Global Recombinant Protein Market, for Others , 2018 - 2030 (USD Million)
  • FIG. 35 Regional Marketplace: Key Takeaways
  • FIG. 36 Regional Outlook, 2021 & 2030
  • FIG. 37 Global Recombinant Protein Market: Region Movement Analysis
  • FIG. 38 North America Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 39 US Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 40 Canada Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 41 Europe Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 42 Germany Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 43 UK Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 44 France Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 45 Italy Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 46 Spain Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 47 Asia Pacific Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 48 Japan Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 49 China Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 50 India Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 51 Australia Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 52 South Korea Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 53 Latin America Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 54 Brazil Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 55 Mexico Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 56 Argentina Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 57 Middle East and Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 58 South Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 59 Saudi Arabia Recombinant Protein Market, 2018 - 2030 (USD Million)
  • FIG. 60 UAE Recombinant Protein Market, 2018 - 2030 (USD Million)